Brachytherapie und „drug-eluting stents“ View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2004-05

AUTHORS

G. Tepe

ABSTRACT

Increasing numbers of atherosclerotic vessel stenoses are treated with percutaneous transluminal angioplasty. One major limitation of this procedure is intimal hyperplasia which leads to restenosis in 15–50% after 6 months. Low rates of restenosis are expected in the carotid artery, but rates are higher in the coronary arteries and in the superficial femoral artery. Because intimal hyperplasia is caused by many reasons, different treatment modalities have failed to reduce the restenosis rate in the last few years. This has dramatically changed with increasing use of brachytherapy and drug-eluting stents. Both treatment modalities have been recently approved for clinical use in special indications. This article summarizes the pathophysiological background of intimal hyperplasia and recent studies which deal with brachytherapy and drug-eluting stents for prevention of restenosis. More... »

PAGES

96-104

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00772-004-0341-8

DOI

http://dx.doi.org/10.1007/s00772-004-0341-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1031110879


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Abteilung f\u00fcr Radiologische Diagnostik, Eberhard-Karls-Universit\u00e4t T\u00fcbingen, Hoppe-Seyler-Str. 3, 72076, T\u00fcbingen", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Abteilung f\u00fcr Radiologische Diagnostik, Eberhard-Karls-Universit\u00e4t T\u00fcbingen", 
            "Abteilung f\u00fcr Radiologische Diagnostik, Eberhard-Karls-Universit\u00e4t T\u00fcbingen, Hoppe-Seyler-Str. 3, 72076, T\u00fcbingen"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tepe", 
        "givenName": "G.", 
        "id": "sg:person.01235146031.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235146031.45"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf03043597", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008614418", 
          "https://doi.org/10.1007/bf03043597"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03043606", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007636601", 
          "https://doi.org/10.1007/bf03043606"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02602985", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043677424", 
          "https://doi.org/10.1007/bf02602985"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2004-05", 
    "datePublishedReg": "2004-05-01", 
    "description": "Increasing numbers of atherosclerotic vessel stenoses are treated with percutaneous transluminal angioplasty. One major limitation of this procedure is intimal hyperplasia which leads to restenosis in 15\u201350% after 6\u00a0months. Low rates of restenosis are expected in the carotid artery, but rates are higher in the coronary arteries and in the superficial femoral artery. Because intimal hyperplasia is caused by many reasons, different treatment modalities have failed to reduce the restenosis rate in the last few years. This has dramatically changed with increasing use of brachytherapy and drug-eluting stents. Both treatment modalities have been recently approved for clinical use in special indications. This article summarizes the pathophysiological background of intimal hyperplasia and recent studies which deal with brachytherapy and drug-eluting stents for prevention of restenosis.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00772-004-0341-8", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1115494", 
        "issn": [
          "0948-7034", 
          "1434-3932"
        ], 
        "name": "Gef\u00e4sschirurgie", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "keywords": [
      "drug-eluting stents", 
      "intimal hyperplasia", 
      "treatment modalities", 
      "percutaneous transluminal angioplasty", 
      "superficial femoral artery", 
      "use of brachytherapy", 
      "different treatment modalities", 
      "prevention of restenosis", 
      "transluminal angioplasty", 
      "restenosis rate", 
      "coronary artery", 
      "femoral artery", 
      "pathophysiological background", 
      "carotid artery", 
      "special indications", 
      "vessel stenosis", 
      "clinical use", 
      "hyperplasia", 
      "artery", 
      "stents", 
      "restenosis", 
      "lower rates", 
      "brachytherapy", 
      "Recent studies", 
      "modalities", 
      "angioplasty", 
      "stenosis", 
      "months", 
      "prevention", 
      "rate", 
      "major limitation", 
      "indications", 
      "years", 
      "use", 
      "study", 
      "background", 
      "procedure", 
      "number", 
      "reasons", 
      "limitations", 
      "article", 
      "atherosclerotic vessel stenoses"
    ], 
    "name": "Brachytherapie und \u201edrug-eluting stents\u201c", 
    "pagination": "96-104", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1031110879"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00772-004-0341-8"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00772-004-0341-8", 
      "https://app.dimensions.ai/details/publication/pub.1031110879"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:07", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_391.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00772-004-0341-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00772-004-0341-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00772-004-0341-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00772-004-0341-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00772-004-0341-8'


 

This table displays all metadata directly associated to this object as RDF triples.

113 TRIPLES      22 PREDICATES      70 URIs      59 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00772-004-0341-8 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author N392663a90b2d4fb495768fa29707db12
4 schema:citation sg:pub.10.1007/bf02602985
5 sg:pub.10.1007/bf03043597
6 sg:pub.10.1007/bf03043606
7 schema:datePublished 2004-05
8 schema:datePublishedReg 2004-05-01
9 schema:description Increasing numbers of atherosclerotic vessel stenoses are treated with percutaneous transluminal angioplasty. One major limitation of this procedure is intimal hyperplasia which leads to restenosis in 15–50% after 6 months. Low rates of restenosis are expected in the carotid artery, but rates are higher in the coronary arteries and in the superficial femoral artery. Because intimal hyperplasia is caused by many reasons, different treatment modalities have failed to reduce the restenosis rate in the last few years. This has dramatically changed with increasing use of brachytherapy and drug-eluting stents. Both treatment modalities have been recently approved for clinical use in special indications. This article summarizes the pathophysiological background of intimal hyperplasia and recent studies which deal with brachytherapy and drug-eluting stents for prevention of restenosis.
10 schema:genre article
11 schema:inLanguage en
12 schema:isAccessibleForFree false
13 schema:isPartOf Nec080e5c3ea641c7ae3ec5e07dade3de
14 Nee70ac8fb83942f7aed2eee9a9564f58
15 sg:journal.1115494
16 schema:keywords Recent studies
17 angioplasty
18 artery
19 article
20 atherosclerotic vessel stenoses
21 background
22 brachytherapy
23 carotid artery
24 clinical use
25 coronary artery
26 different treatment modalities
27 drug-eluting stents
28 femoral artery
29 hyperplasia
30 indications
31 intimal hyperplasia
32 limitations
33 lower rates
34 major limitation
35 modalities
36 months
37 number
38 pathophysiological background
39 percutaneous transluminal angioplasty
40 prevention
41 prevention of restenosis
42 procedure
43 rate
44 reasons
45 restenosis
46 restenosis rate
47 special indications
48 stenosis
49 stents
50 study
51 superficial femoral artery
52 transluminal angioplasty
53 treatment modalities
54 use
55 use of brachytherapy
56 vessel stenosis
57 years
58 schema:name Brachytherapie und „drug-eluting stents“
59 schema:pagination 96-104
60 schema:productId N66e39b4555794b18bd94ed280c8f4630
61 N98a4a96bab514bdab6a65995e4dfcb59
62 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031110879
63 https://doi.org/10.1007/s00772-004-0341-8
64 schema:sdDatePublished 2021-11-01T18:07
65 schema:sdLicense https://scigraph.springernature.com/explorer/license/
66 schema:sdPublisher Nff1a96b27a994cf4995d6e3eba48a357
67 schema:url https://doi.org/10.1007/s00772-004-0341-8
68 sgo:license sg:explorer/license/
69 sgo:sdDataset articles
70 rdf:type schema:ScholarlyArticle
71 N392663a90b2d4fb495768fa29707db12 rdf:first sg:person.01235146031.45
72 rdf:rest rdf:nil
73 N66e39b4555794b18bd94ed280c8f4630 schema:name dimensions_id
74 schema:value pub.1031110879
75 rdf:type schema:PropertyValue
76 N98a4a96bab514bdab6a65995e4dfcb59 schema:name doi
77 schema:value 10.1007/s00772-004-0341-8
78 rdf:type schema:PropertyValue
79 Nec080e5c3ea641c7ae3ec5e07dade3de schema:issueNumber 2
80 rdf:type schema:PublicationIssue
81 Nee70ac8fb83942f7aed2eee9a9564f58 schema:volumeNumber 9
82 rdf:type schema:PublicationVolume
83 Nff1a96b27a994cf4995d6e3eba48a357 schema:name Springer Nature - SN SciGraph project
84 rdf:type schema:Organization
85 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
86 schema:name Medical and Health Sciences
87 rdf:type schema:DefinedTerm
88 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
89 schema:name Cardiorespiratory Medicine and Haematology
90 rdf:type schema:DefinedTerm
91 sg:journal.1115494 schema:issn 0948-7034
92 1434-3932
93 schema:name Gefässchirurgie
94 schema:publisher Springer Nature
95 rdf:type schema:Periodical
96 sg:person.01235146031.45 schema:affiliation grid-institutes:None
97 schema:familyName Tepe
98 schema:givenName G.
99 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235146031.45
100 rdf:type schema:Person
101 sg:pub.10.1007/bf02602985 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043677424
102 https://doi.org/10.1007/bf02602985
103 rdf:type schema:CreativeWork
104 sg:pub.10.1007/bf03043597 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008614418
105 https://doi.org/10.1007/bf03043597
106 rdf:type schema:CreativeWork
107 sg:pub.10.1007/bf03043606 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007636601
108 https://doi.org/10.1007/bf03043606
109 rdf:type schema:CreativeWork
110 grid-institutes:None schema:alternateName Abteilung für Radiologische Diagnostik, Eberhard-Karls-Universität Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen
111 schema:name Abteilung für Radiologische Diagnostik, Eberhard-Karls-Universität Tübingen
112 Abteilung für Radiologische Diagnostik, Eberhard-Karls-Universität Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen
113 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...